Tyra Biosciences (TYRA) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free TYRA Stock Alerts $19.10 +0.66 (+3.58%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 6:51 PM | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Up 4.7%Tyra Biosciences (NASDAQ:TYRA) Shares Up 4.7%May 15 at 3:54 AM | americanbankingnews.comTyra Biosciences' (TYRA) Outperform Rating Reaffirmed at OppenheimerMay 14 at 5:18 AM | americanbankingnews.comWedbush Weighs in on Tyra Biosciences, Inc.'s Q1 2025 Earnings (NASDAQ:TYRA)May 13, 2024 | markets.businessinsider.comBuy Rating Affirmed: TYRA-300’s Progress and Potent FGFR3 Inhibition Signal Promising Outcomes for Tyra BioscienceMay 13, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Rating Reiterated by OppenheimerOppenheimer reaffirmed an "outperform" rating and set a $28.00 price objective (up from $25.00) on shares of Tyra Biosciences in a report on Monday.May 13, 2024 | americanbankingnews.comTyra Biosciences, Inc. (NASDAQ:TYRA) to Post Q1 2025 Earnings of ($0.41) Per Share, Wedbush ForecastsMay 12, 2024 | americanbankingnews.comWedbush Reiterates "Outperform" Rating for Tyra Biosciences (NASDAQ:TYRA)May 12, 2024 | americanbankingnews.comTyra Biosciences (NASDAQ:TYRA) Rating Reiterated by HC WainwrightMay 11, 2024 | markets.businessinsider.comBuy Rating for Tyra Bioscience Amid Promising TYRA-300 Developments and Strong FinancialsMay 10, 2024 | marketbeat.comWedbush Reaffirms Outperform Rating for Tyra Biosciences (NASDAQ:TYRA)Wedbush reissued an "outperform" rating and issued a $28.00 price target on shares of Tyra Biosciences in a research note on Friday.May 10, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Tyra Biosciences (NASDAQ:TYRA)HC Wainwright reaffirmed a "buy" rating and issued a $23.00 target price on shares of Tyra Biosciences in a research report on Friday.May 10, 2024 | investorplace.comTYRA Stock Earnings: Tyra Biosciences Beats EPS for Q1 2024May 9, 2024 | prnewswire.comTyra Biosciences Reports First Quarter 2024 Financial Results and HighlightsMay 7, 2024 | prnewswire.comTyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S.April 29, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Stock Price Up 6.5%Tyra Biosciences (NASDAQ:TYRA) Trading Up 6.5%April 25, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Down 7.3% Tyra Biosciences (NASDAQ:TYRA) Trading Down 7.3%April 10, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 8.3%Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 8.3%March 27, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Gap Up to $16.15Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up to $16.15March 26, 2024 | markets.businessinsider.comTyra Bioscience Poised for Growth: Buy Rating Affirmed Amid Promising Clinical Trials and Strategic Drug DevelopmentMarch 22, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Sees Unusually-High Trading VolumeTyra Biosciences (NASDAQ:TYRA) Sees Strong Trading VolumeMarch 22, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Tyra Biosciences, Inc.'s Q1 2024 Earnings (NASDAQ:TYRA)Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - HC Wainwright decreased their Q1 2024 earnings per share estimates for shares of Tyra Biosciences in a research note issued to investors on Wednesday, March 20th. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.53) peMarch 21, 2024 | marketbeat.comTyra Biosciences' (TYRA) "Outperform" Rating Reiterated at WedbushWedbush reissued an "outperform" rating and issued a $28.00 target price on shares of Tyra Biosciences in a research report on Thursday.March 21, 2024 | marketbeat.comAnalysts Set Expectations for Tyra Biosciences, Inc.'s FY2025 Earnings (NASDAQ:TYRA)Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - Research analysts at HC Wainwright issued their FY2025 earnings estimates for shares of Tyra Biosciences in a research note issued on Wednesday, March 20th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings per shareMarch 20, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Receives "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $23.00 price objective (up from $19.00) on shares of Tyra Biosciences in a research report on Wednesday.March 19, 2024 | msn.comTYRA Stock Earnings: Tyra Biosciences Misses EPS for Q4 2023March 19, 2024 | finance.yahoo.comTyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline ProgressMarch 19, 2024 | msn.comTyra Biosciences files to sell 15.37M shares of common stock for holdersMarch 19, 2024 | finance.yahoo.comTyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and HighlightsMarch 19, 2024 | marketbeat.comTyra Biosciences (TYRA) Scheduled to Post Earnings on WednesdayTyra Biosciences (NASDAQ:TYRA) will be releasing earnings on Wednesday, March 20, Yahoo Finance reports.March 18, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Down 5.9% Tyra Biosciences (NASDAQ:TYRA) Shares Down 5.9%March 18, 2024 | insidertrades.comTyra Biosciences, Inc. (NASDAQ:TYRA) COO Daniel Bensen Sells 1,733 SharesMarch 8, 2024 | marketbeat.comInsider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) COO Sells 1,733 Shares of StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) COO Daniel Bensen sold 1,733 shares of the company's stock in a transaction dated Wednesday, March 6th. The stock was sold at an average price of $20.09, for a total transaction of $34,815.97. Following the completion of the sale, the chief operating officer now owns 431,951 shares in the company, valued at approximately $8,677,895.59. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.March 6, 2024 | finance.yahoo.comInsider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 SharesMarch 1, 2024 | finance.yahoo.comInsider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 SharesMarch 1, 2024 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Fmr LLCFmr LLC reduced its stake in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 5.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,898,827 shares of the company's stock after selling 218,042 shares during the quarter. Fmr LLC owned approximFebruary 27, 2024 | prnewswire.comTyra Biosciences to Present at Upcoming Investor ConferencesFebruary 24, 2024 | msn.comTyra Biosciences (TYRA) Price Target Increased by 5.41% to 23.87February 17, 2024 | finance.yahoo.comTYRA Mar 2024 20.000 callFebruary 17, 2024 | finance.yahoo.comTYRA Mar 2024 20.000 putFebruary 15, 2024 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Sees Significant Growth in Short InterestTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 2,040,000 shares, an increase of 8.5% from the January 15th total of 1,880,000 shares. Based on an average trading volume of 99,800 shares, the short-interest ratio is currently 20.4 days. Approximately 10.8% of the shares of the stock are sold short.February 15, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.2% Following Insider SellingTyra Biosciences (NASDAQ:TYRA) Shares Down 4.2% Following Insider SellingFebruary 12, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Reaches New 12-Month High at $20.00Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High at $20.00February 9, 2024 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) COO Daniel Bensen Sells 9,587 SharesTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) COO Daniel Bensen sold 9,587 shares of Tyra Biosciences stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $18.09, for a total value of $173,428.83. Following the completion of the transaction, the chief operating officer now owns 452,981 shares in the company, valued at $8,194,426.29. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.February 7, 2024 | finance.yahoo.comTyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences ConferenceFebruary 7, 2024 | finance.yahoo.comPresident and CEO Todd Harris Sells 100,000 Shares of Tyra Biosciences Inc (TYRA)February 6, 2024 | msn.comTyra Bioscience Announces New Purchase AgreementFebruary 6, 2024 | msn.comTyra Bioscience Secures $200M for Clinical Drug DevelopmentFebruary 2, 2024 | nasdaq.comTyra Biosciences Climbs 23% After Announcing $200 Mln Private PlacementFebruary 2, 2024 | marketwatch.comTyra Shares Jump After $200 Million Private Placement FundingFebruary 2, 2024 | msn.comTyra Biosciences spikes on $200M private financing Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… TYRA Media Mentions By Week TYRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TYRA News Sentiment▼0.740.54▲Average Medical News Sentiment TYRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TYRA Articles This Week▼191▲TYRA Articles Average Week Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SAVA News IMNM News OCUL News ABVX News SPRY News ARQT News CNTA News OPK News LQDA News INVA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TYRA) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
